• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Rockefeller Plaza display underscores Lighthouse International’s vision loss programs


See Lighthouse International's current advertising campaign, "Will I be able to read?", in a display window at Rockefeller Center.


New York-”Will I be able to read?” is the question that someone diagnosed with macular degeneration, glaucoma, retinitis pigmentosa, or other eye diseases always asks.

“Will I Be Able to Read?” also is the title of Lighthouse International’s current advertising campaign, which is showcased in a display window in Rockefeller Center. EHE International, a leader in preventive healthcare, donated the display space. The 180” x 83” display will be in Rockefeller Plaza through January 31.

Said Deborah McKeever, president of EHE International, “Together we hope to enlighten, inform and raise awareness about vision loss and empower those living with vision loss and their caregivers through the resources available at Lighthouse International.”

The ad campaign’s focus is to let individuals with vision loss, as well as their families, caregivers, and loved ones, know that there is help, hope, and resources available to enhance their quality of life and enable them to live safely and independently. Lighthouse International offers services and programs that help people of all ages overcome the challenges of vision loss.


Read more articles from this week's News Flash.

Related Videos
Lorraine Provencher, MD, presenting slides
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Melissa Tawa, OD, FAAO
Deborah Ristvedt, DO, details CIME 2024 presentation on glaucoma management
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Nate Lighthizer, OD, speaks on lasers in optometry at AAOpt 2023
© 2024 MJH Life Sciences

All rights reserved.